Q/C Technologies, Inc. (QCLS) — 8-K Filings

8-K Filings (25)

• 8-K Filing — Dec 9, 2025
• Q/C Technologies Files 8-K: Officer/Director Changes & Shareholder Votes — Nov 14, 2025 Risk: medium
  On November 14, 2025, Q/C Technologies, Inc. filed an 8-K report detailing several key events. These include the departure of directors or certain officers, the
• Q/C Technologies, Inc. Files 8-K: Material Agreements & Equity Changes — Oct 3, 2025 Risk: medium
  On September 30, 2025, Q/C Technologies, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities
• Q/C Technologies Files 8-K with Bylaw Amendments — Sep 26, 2025 Risk: low
  On September 22, 2025, Q/C Technologies, Inc. filed an 8-K report detailing amendments to its Articles of Incorporation or Bylaws, a Regulation FD disclosure, a
• TNF Pharmaceuticals Files 8-K: Material Agreement & Bylaw Changes — Sep 10, 2025 Risk: medium
  On September 4, 2025, TNF Pharmaceuticals, Inc. (formerly MyMD Pharmaceuticals, Inc.) entered into a material definitive agreement. The company also made modifi
• TNF Pharmaceuticals Announces Material Agreements & Officer Changes — Sep 2, 2025 Risk: medium
  On August 28, 2025, TNF Pharmaceuticals, Inc. entered into a material definitive agreement and simultaneously terminated another. The company also reported unre
• TNF Pharmaceuticals Holds Shareholder Vote on Reverse Split — Jun 6, 2025 Risk: medium
  On June 3, 2025, TNF Pharmaceuticals, Inc. filed an 8-K report detailing several key events. The company announced a special meeting of stockholders to vote on
• TNF Pharmaceuticals Files 8-K for Bylaw Amendments & Exhibits — May 9, 2025 Risk: low
  On May 9, 2025, TNF Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns amendments to its Articles of Incorporation or Bylaws and the submi
• TNF Pharmaceuticals Faces Delisting Concerns — Mar 21, 2025 Risk: high
  TNF Pharmaceuticals, Inc. (formerly MyMD Pharmaceuticals, Inc.) filed an 8-K on March 21, 2025, reporting a notice of delisting or failure to satisfy a continue
• TNF Pharmaceuticals Files 8-K Report — Mar 10, 2025 Risk: low
  On March 6, 2025, TNF Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns a Regulation FD Disclosure and the inclusion of Financial Stateme
• TNF Pharmaceuticals Files 8-K: Director Changes & More — Nov 26, 2024 Risk: medium
  On November 25, 2024, TNF Pharmaceuticals, Inc. filed an 8-K report detailing several key events. The company announced the departure of a director, the electio
• TNF Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — Oct 7, 2024 Risk: medium
  On October 1, 2024, TNF Pharmaceuticals, Inc. (formerly MyMD Pharmaceuticals, Inc.) entered into a material definitive agreement. The company also reported on u
• TNF Pharmaceuticals Files 8-K on Accountant Change — Oct 4, 2024 Risk: low
  On September 30, 2024, TNF Pharmaceuticals, Inc. (formerly MyMD Pharmaceuticals, Inc.) filed an 8-K report. The filing primarily concerns changes in the company
• TNF Pharmaceuticals Files 8-K on Shareholder Nominations — Sep 23, 2024 Risk: medium
  On September 20, 2024, TNF Pharmaceuticals, Inc. filed an 8-K report detailing shareholder nominations for its upcoming annual meeting. The company, formerly kn
• TNF Pharmaceuticals Files 8-K on Material Agreement — Aug 14, 2024 Risk: medium
  On August 8, 2024, TNF Pharmaceuticals, Inc. filed an 8-K report detailing a material definitive agreement. The company, formerly known as MyMD Pharmaceuticals,
• TNF Pharmaceuticals Changes Fiscal Year End — Jul 26, 2024 Risk: low
  On July 22, 2024, TNF Pharmaceuticals, Inc. filed an 8-K report detailing a change in its fiscal year end to December 31st, previously it was not explicitly sta
• MyMD Pharmaceuticals Files 8-K on Security Holder Rights — Jun 24, 2024 Risk: medium
  MyMD Pharmaceuticals, Inc. filed an 8-K on June 17, 2024, reporting material modifications to the rights of security holders and amendments to its articles of i
• MyMD Pharmaceuticals Announces Corporate Changes — Jun 17, 2024 Risk: medium
  MyMD Pharmaceuticals, Inc. announced on June 13, 2024, a series of significant corporate actions. These include entering into a material definitive agreement, m
• MyMD Pharmaceuticals Files 8-K on Security Holder Rights — May 23, 2024 Risk: medium
  MyMD Pharmaceuticals, Inc. filed an 8-K on May 23, 2024, reporting material modifications to security holder rights and other events as of May 21, 2024. The fil
• MyMD Pharmaceuticals Files 8-K: Agreements, Equity Sales, Bylaw Changes — May 21, 2024 Risk: medium
  MyMD Pharmaceuticals, Inc. announced on May 20, 2024, that it entered into a Material Definitive Agreement. The company also reported on unregistered sales of e
• MyMD Pharmaceuticals Board Changes — Apr 18, 2024 Risk: medium
  MyMD Pharmaceuticals, Inc. announced on April 15, 2024, a change in its board of directors. Specifically, Dr. Jonathan L. Cohen has resigned from his position a
• MyMD Pharmaceuticals Reports Material Events and Officer Changes — Apr 8, 2024 Risk: medium
  MyMD Pharmaceuticals, Inc. filed an 8-K on April 8, 2024, reporting several material events as of April 5, 2024. These include entering into a material definiti
• MyMD Pharmaceuticals Files 8-K: Material Agreements & Bylaw Changes — Mar 7, 2024 Risk: medium
  MyMD Pharmaceuticals, Inc. announced on March 4, 2024, that it entered into a material definitive agreement. The company also reported material modifications to
• MyMD Pharmaceuticals Files 8-K — Mar 5, 2024 Risk: low
  MyMD Pharmaceuticals, Inc. filed an 8-K on March 5, 2024, to report on a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly k
• MyMD Pharma Files 8-K on Shareholder Rights, Bylaw Changes — Feb 13, 2024 Risk: medium
  MyMD Pharmaceuticals, Inc. filed an 8-K on February 13, 2024, reporting material modifications to the rights of its security holders and amendments to its artic

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX